Quantum BioPharma signs PPD contract for Phase 2 MS trial
Quantum BioPharma has signed a study start-up agreement with Thermo Fisher’s PPD clinical research unit to implement a Phase 2 trial of Lucid-MS for progressive multiple sclerosis.
Quantum BioPharma has signed a study start-up agreement with Thermo Fisher’s PPD clinical research unit to implement a Phase 2 trial of Lucid-MS for progressive multiple sclerosis.